15 May 2024
15 May 2024
CircRNA is still in very early days of development, but it is expected to trialled in vaccines, therapeutics and biomarkers trials in the next few years.
Highly potent active pharmaceutical ingredients (HPAPIs) are essential for chemotherapies and combination therapies. With specialised production facilities in great demand, what are the key challenges in HPAPI manufacturing?
The two companies will develop neuroplastogens for psychiatric disorders as psychedelic market activity ramps up.
Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelto market in its Q1 update.
A big topic at Arena International’s Outsourcing in Clinical Trials Europe 2024 is how everyone should benefit from clinical research.
Dandelion Health’s AI database can be used as a tool for sponsors to decide which indications to next investigate GLP1-RAs in.
Walden reported positive topline data from a Phase I clinical trial of its lead candidate WAL0921, a humanised mAb to treat kidney disease.
Cytokinetics plans to file for approval in both the US and Europe for its hypertrophic cardiomyopathy therapy by the end of the year.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
